Home » Flamel Technologies’ Akovaz Scoops Up FDA Approval
Flamel Technologies’ Akovaz Scoops Up FDA Approval
May 6, 2016
Flamel Technologies has secured FDA approval for its surgical hypotension drug Akovaz.
The company said it will launch the injectable drug at a 50 mg/mL dosage at some point in the third quarter. Flamel is the first company to receive FDA approval for this formulation of the drug.
Upcoming Events
-
21Oct